J. Schläpfer

发表

Computer-Interpreted Electrocardiograms: Benefits and Limitations.

H. Wellens, J. Schläpfer, 2017, Journal of the American College of Cardiology.

Experience with a New Implantable Pacer‐, Cardioverter‐Defibrillator for the Therapy of Recurrent Sustained Ventricular Tachyarrhythmias: A Step Toward a Universal Ventricular Tachyarrhythmia Control Device

J. Schläpfer, L. Kappenberger, M. Fromer, 1991, Pacing and clinical electrophysiology : PACE.

Acute Hemodynamic Effects of Atrioventricular Pacing at Differing Sites in the Right Ventricle Individually and Simultaneously

J. Schläpfer, L. Kappenberger, L. Kappenberger, 1997, Pacing and clinical electrophysiology : PACE.

Age at onset and gender of patients with different types of supraventricular tachycardias.

H. Wellens, J. Smeets, J. Schläpfer, 1992, The American journal of cardiology.

Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up.

J. Schläpfer, L. Kappenberger, M. Fromer, 2002, Journal of the American College of Cardiology.

What risk should justify implantable cardioverter defibrillator therapy?

J. Schläpfer, L. Kappenberger, M. Fromer, 1999, The American journal of cardiology.

Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trial.

R. Stupp, S. Leyvraz, C. Sessa, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Mechanisms of AV node modulation in AV node reentry tachycardia.

J. Schläpfer, L. Kappenberger, 1995, Journal of interventional cardiology.

ACTN2 variant associated with a cardiac phenotype suggestive of left-dominant arrhythmogenic cardiomyopathy

J. Schläpfer, F. Fellmann, Z. Bhuiyan, 2019, HeartRhythm case reports.

Stepwise evaluation of syncope: a prospective population-based controlled study.

J. Sztajzel, B. Yersin, J. Schläpfer, 2008, International journal of cardiology.

Long-term risk of adverse outcomes according to atrial fibrillation type

F. Eberli, D. Conen, K. Lovblad, 2022, Scientific Reports.

Ten‐Years Follow‐Up of 20 Patients with Idiopathic Ventricular Tachycardia

J. Schläpfer, J. Goy, L. Kappenberger, 1990, Pacing and clinical electrophysiology : PACE.

The 12-lead electrocardiogram in midseptal, anteroseptal, posteroseptal and right free wall accessory pathways.

H. Wellens, J. Smeets, O. Penn, 1993, The American journal of cardiology.

Clinical Experience with Dual-Chamber Rate Responsive Pacemakers

J. Schläpfer, J. Goy, L. Kappenberger, 1989 .

Atypical Electrocardiographic Presentations in Need of Primary Percutaneous Coronary Intervention.

B. Harbaoui, J. Schläpfer, O. Muller, 2019, The American journal of cardiology.

Sudden cardiac death in the young (5-39 years) in the canton of Vaud, Switzerland

J. Schläpfer, F. Fellmann, K. Michaud, 2014, BMC Cardiovascular Disorders.

Silent brain infarcts impact on cognitive function in atrial fibrillation

D. Conen, A. Monsch, S. Aeschbacher, 2022, European heart journal.

Atrial fibrillation, complete atrioventricular block and escape rhythm with bundle-branch block morphologies: an exceptional presentation of Lyme carditis.

N. Wenger, J. Schläpfer, C. Pellaton, 2012, International journal of cardiology.

Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy.

T. Buclin, J. Biollaz, J. Schläpfer, 2004, Swiss medical weekly.

Stereoselective Block of hERG Channel by (S)‐Methadone and QT Interval Prolongation in CYP2B6 Slow Metabolizers

P. Carrupt, J. Schläpfer, J. Rougier, 2007, Clinical pharmacology and therapeutics.

Reduced Atrial Emptying after Orthotopic Heart Transplantation Masquerading as Restrictive Transmitral Doppler Flow Pattern? *

J. Schläpfer, P. Pascale, P. Monney, 2011, Echocardiography.

Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc interval.

C. Eap, J. Schläpfer, M. Faouzi, 2010, Archives of internal medicine.

Recurrent cardioembolic stroke related to late dislodgement of a right atrial pacing lead into the left atrium.

J. Schläpfer, L. Kappenberger, N. Aebischer, 1999, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

QTc interval, cardiovascular events and mortality in patients with atrial fibrillation.

D. Conen, S. Aeschbacher, D. Shah, 2018, International journal of cardiology.

Uptake of non-vitamin K antagonist oral anti coagulants in patients with atrial fibrillation - a prospective cohort study.

D. Conen, D. Shah, P. Erne, 2017, Swiss medical weekly.

Catheter ablation for atrial fibrillation: pathophysiology, techniques, results and current indications

J. Schläpfer, C. Sticherling, S. Osswald, 2005 .

Guidelines for the clinical management of atrial fibrillation: a practical perspective.

J. Cornuz, J. Schläpfer, P. Nicod, 2004, Swiss medical weekly.

Bezold‐Jarisch‐Like Phenomenon Induced by Radiofrequency Ablation of a Left Posteroseptal Accessory Pathway via the Coronary Sinus

J. Schläpfer, L. Kappenberger, M. Fromer, 1996, Journal of cardiovascular electrophysiology.

Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation.

D. Conen, A. Monsch, S. Aeschbacher, 2019, Journal of the American College of Cardiology.

Prevalence and predictors of atrial fibrillation type among individuals with recent onset of atrial fibrillation.

D. Conen, S. Aeschbacher, D. Shah, 2018, Swiss medical weekly.

Dual Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy: Beneficial Effect of Atrioventricular Junction Ablation for Optimal Left Ventricular Capture and Filling

J. Schläpfer, L. Kappenberger, M. Fromer, 1997, Pacing and clinical electrophysiology : PACE.

Clinical characteristics and electrophysiologic properties of atrioventricular accessory pathways: importance of the accessory pathway location.

H. Wellens, J. Smeets, J. Schläpfer, 1992, Journal of the American College of Cardiology.

Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations.

J. Schläpfer, P. Guicheney, J. Rougier, 2005, Cardiovascular research.

Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome.

J. Kautzner, F. Sacher, M. Hocini, 2015, Journal of the American College of Cardiology.

Prospective Assessment of Sex‐Related Differences in Symptom Status and Health Perception Among Patients With Atrial Fibrillation

D. Conen, S. Aeschbacher, D. Shah, 2017, Journal of the American Heart Association.

Radiofrequency Catheter Ablation of Three Accessory Pathways in a Single Session

J. Smeets, J. Schläpfer, B. Dijkman, 1992 .

Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants

D. Conen, S. Aeschbacher, N. Rodondi, 2021, Journal of thrombosis and haemostasis : JTH.

Use of the wearable cardioverter-defibrillator - the Swiss experience.

Jan van den Berg, U. Eriksson, G. Domenichini, 2020, Swiss medical weekly.

[Intravenous withdrawal of infected cardiac pacemaker electrodes. Apropos of 5 cases].

J. Schläpfer, L. Kappenberger, M. Fromer, 1996, Annales de cardiologie et d'angeiologie.

Incidence and Predictors of Atrial Fibrillation Progression

D. Conen, S. Aeschbacher, D. Shah, 2019, Journal of the American Heart Association.

Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.

J. Schläpfer, T. Jespersen, J. Kucera, 2008, Cardiovascular research.

Clinical factors associated with the intraventricular conduction disturbances in Swiss middle-aged adults: The CoLaus|PsyCoLaus study.

P. Vollenweider, J. Schläpfer, P. Marques-Vidal, 2020, International journal of cardiology.

Late clinical outcome after successful radiofrequency catheter ablation of accessory pathways.

J. Schläpfer, M. Fromer, 2001, European heart journal.

Risk factors for heart failure hospitalizations among patients with atrial fibrillation

D. Conen, S. Aeschbacher, D. Shah, 2018, PloS one.

Patients with syncope remaining unexplained after a structured work-up share the characteristics of patients with neurally mediated syncope

J. Sztajzel, J. Schläpfer, O. Hugli, 2020 .

Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients

C. Eap, J. Schläpfer, P. Conus, 2019, Therapeutic advances in psychopharmacology.

[Permanent junctional reciprocating tachycardia: a little-known clinical entity curable with radiofrequency ablation].

J. Schläpfer, L. Kappenberger, M. Fromer, 1995, Schweizerische medizinische Wochenschrift.

Clinical determinants of the PR interval duration in Swiss middle‐aged adults: The CoLaus/PsyCoLaus study

P. Vollenweider, J. Schläpfer, E. Pruvot, 2020, Clinical cardiology.

Radiofrequency catheter ablation of both atrial ventricular nodal reentrant and atrial ventricular reentrant tachycardia in a single session

J. Schläpfer, J. Goy, 1994, Clinical cardiology.

Form "fruste" of long QT syndrome as a possible cause for unexplained syncope revealed by dobutamine infusion.

J. Schläpfer, E. Pruvot, E. Gollut, 2006, International journal of cardiology.